The World Health Organization is currently examining Merck antiviral drug against COVID-19 and a recommendation is possible by early February, an official said today.
Janet Dias, head of clinical management at the WHO, said that the WHO Instruction Development Team is also preparing to test the Pfizer pill.
“We will look at this data (for the Pfizer pill) in early February for publication possibly later that month.”
Late yesterday, Thursday, a committee of the WHO. recommended the use of two drugs by Eli Lilly and GlaxoSmithKline and Vir Biotechnology for patients with COVID-19, increasing treatment options, as the rapidly transmitted Omicron variant makes some ineffective.
Referring to monoclonal antibody therapies, Dias said that some monoclonals show reduced neutralization against the highly contagious Omicron and may be less effective against this variant.
However, he said that it does not “bring upside down”, as many treatment options are now available for COVID-19.
“We are monitoring the antivirals for the development of resistance,” the WHO official added.
Source: AMPE
.
Source From: Capital
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
